APA Citatie

Liu, H., Takagaki, Y., Kumagai, A., Kanasaki, K., & Koya, D. (2020). The PKM2 activator TEPP‐46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF‐1α accumulation. J Diabetes Investig.

Chicago Style citaat

Liu, Haijie, Yuta Takagaki, Asako Kumagai, Keizo Kanasaki, en Daisuke Koya. "The PKM2 Activator TEPP‐46 Suppresses Kidney Fibrosis Via Inhibition of the EMT Program and Aberrant Glycolysis Associated With Suppression of HIF‐1α Accumulation." J Diabetes Investig 2020.

MLA citatie

Liu, Haijie, et al. "The PKM2 Activator TEPP‐46 Suppresses Kidney Fibrosis Via Inhibition of the EMT Program and Aberrant Glycolysis Associated With Suppression of HIF‐1α Accumulation." J Diabetes Investig 2020.